BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261113
DTEND;VALUE=DATE:20261115
DTSTAMP:20260826T134459Z
CREATED:20260826T134459Z
LAST-MODIFIED:20260826T134459Z
UID:10000961-1794528000-1794700799@oncodaily.com
SUMMARY:The ESMO Advanced Course on Cholangiocarcinoma 2026
DESCRIPTION:The ESMO Advanced Course on Cholangiocarcinoma 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 13–14\, 2026\, in Barcelona\, Spain. \nThe course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma\, covering diagnostic challenges\, clinical and molecular differences between disease subtypes\, adjuvant and palliative treatment strategies\, surgery and other locoregional therapies\, immunotherapy\, and currently available and emerging targeted treatments for advanced disease. \nThe programme is aimed at oncology professionals seeking deeper practical knowledge of this complex malignancy and has been accredited with 11 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/advanced-course-on-cholangiocarcinoma-574980
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-05_12_07-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261127
DTSTAMP:20260903T202512Z
CREATED:20260903T202437Z
LAST-MODIFIED:20260903T202512Z
UID:10000992-1795564800-1795737599@oncodaily.com
SUMMARY:ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2− mBC Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 25\, 2026\, in Barcelona\, Spain. \nThe course will focus on the increasingly complex management of hormone receptor-positive\, HER2-negative metastatic breast cancer\, particularly how clinicians define endocrine sensitivity and resistance and use these distinctions to guide treatment decisions. \nThe programme is designed to support evidence-based therapeutic selection and sequencing as treatment options for HR+/HER2− metastatic disease continue to expand\, with emphasis on integrating clinical and molecular information into individualized patient management.
URL:https://oncodaily.com/event/endocrine-sensitivity-580276
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-4-2026-12_22_08-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270511
DTEND;VALUE=DATE:20270514
DTSTAMP:20260929T122126Z
CREATED:20260929T122126Z
LAST-MODIFIED:20260929T122126Z
UID:10001075-1809993600-1810252799@oncodaily.com
SUMMARY:EACR – Defence is the Best Attack: Immuno-Oncology Breakthroughs
DESCRIPTION:The EACR – Defence is the Best Attack: Immuno-Oncology Breakthroughs conference will take place from May 11–13\, 2027\, in Barcelona\, Spain.  \nOrganized by the European Association for Cancer Research (EACR)\, the conference will bring together leading basic and translational scientists and clinicians to discuss the latest advances in immuno-oncology\, from fundamental discoveries to clinical applications. \nThe meeting will focus on how advances in understanding the interaction between tumours and the immune system are shaping new therapeutic strategies. The programme will explore immune checkpoints\, innate immune responses\, immune cell therapies\, cancer vaccines\, biomarkers of response\, and mechanisms of resistance to immunotherapy. \nThrough discussions spanning molecular mechanisms\, novel therapeutic targets\, and clinical studies\, the conference will highlight emerging approaches aimed at expanding the number of patients who benefit from cancer immunotherapies. \n 
URL:https://oncodaily.com/event/immuno-oncology-breakthroughs-596790
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-29-2026-04_20_38-PM.webp
END:VEVENT
END:VCALENDAR